A new mutation in the hMSH2 gene in a Spanish Lynch syndrome family
Clinical Genetics Unit, University Clinic of Navarra, Pamplona, Navarra, Spain.Clinical and Translational Oncology (Impact Factor: 2.08). 12/2010; 12(12):849-51. DOI: 10.1007/s12094-010-0596-3
We report a new germline mutation in exon 13 of the hMSH2 gene (c.2081T>C; F694S) in a patient diagnosed with colorectal carcinoma. The patient's family fulfilled the clinical criteria of the Bethesda guidelines for Lynch syndrome. The segregation analysis determined the presence of the mutation in the proband's mother (breast cancer younger than 40 years old) and in two healthy daughters. The mutation was not present in 116 normal controls screened. The medical implications for the carrier relatives are discussed.
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.